Resumo:
En
|
Texto:
En
|
PDF:
En
Although non-invasive prenatal testing (NIPT) is widely used to detect fetal abnormalities, the results of NIPT vary by population, and data for the screening efficiency of NIPT positive predictive value (PPV) from different populations is limited. Herein, we retrospectively analyzed the NIPT results in a large multicenter study involving 52,855 pregnant women. Depending on gestational age, amniotic fluid or umbilical cord blood was extracted for karyotype and/or chromosome microarray analysis (CMA) in NIPT-positive patients, and the PPV and follow-up data were evaluated to determine its clinical value. Among the 52,855 cases, 754 were NIPT-positive, with a positivity rate of 1.4%. Karyotype analysis and/or CMA confirmed 323 chromosomal abnormalities, with a PPV of 45.1%. PPV for trisomy 21 (T21), trisomy 18 (T18), trisomy 13 (T13), sex chromosomal aneuploidies (SCAs), and copy number variations (CNVs) were 78.9, 35.3, 22.2, 36.9, and 32.9%, respectively. The PPVs for T21, T18, and T13 increased with age, whereas the PPVs for SCAs and CNVs had little correlation with age. The PPV was significantly higher in patients with advanced age and abnormal ultrasound. The NIPT results are affected by population characteristics. NIPT had a high PPV for T21 and a low PPV for T13 and T18, and screening for SCAs and CNVs showed clinical significance in southern China. noninvasive non invasive (NIPT abnormalities (PPV limited Herein 52855 52 855 52,85 women andor (CMA NIPTpositive followup follow up cases 75 NIPTpositive, positive, 14 1 4 1.4% 32 451 45 45.1% 2 T , (T21) T18 (T18) T13, (T13) SCAs, (SCAs) (CNVs 789 78 9 78.9 353 35 3 35.3 222 22 22.2 369 36 36.9 329 32.9% respectively T1 ultrasound characteristics T2 China 5285 5 85 52,8 7 1.4 45.1 (T21 (T18 (T13 (SCAs 78. 35. 22. 36. 32.9 528 8 52, 1. 45. (T2 (T1 32. (T